✦ LIBER ✦

Genetic prodrug activation therapy

✍ Scribed by LA Martin; R Vile; NR Lemoine; K Sikora; HS Pandha

Book ID: 118550846
Publisher: The Lancet
Year: 1997
Tongue: English
Weight: 99 KB
Volume: 350
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(05)63633-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Developments in genetic prodrug activati

Developments in genetic prodrug activation therapy

📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 148 KB

Genetic Prodrug Activation Therapy for P

Genetic Prodrug Activation Therapy for Pancreatic Cancer

✍ A. S. RIGG; N. R. LEMOINE 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

Cell death associated with genetic prodr

Cell death associated with genetic prodrug activation therapy of colorectal cancer

✍ Stephen Todryk; Alan Melcher; Graham Bottley; Michael Gough; Richard Vile 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 213 KB

The role of adenoviral vectors in geneti

The role of adenoviral vectors in genetic prodrug activation therapy in prostate cancer

✍ Eaton, J D; Clarke, I A; Pandha, H; Dalgleish, A G; Kirby, R S 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 34 KB

Prodrug activation enzymes in cancer gen

Prodrug activation enzymes in cancer gene therapy

✍ Manish Aghi; Fred Hochberg; Xandra O. Breakefield 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

Among the broad array of genes that have been evaluated for tumor therapy, those encoding prodrug activation enzymes are especially appealing as they directly complement ongoing clinical chemotherapeutic regimes. These enzymes can activate prodrugs that have low inherent toxicity using both bacteria

Targeted delivery of chemotherapeutics:

Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy

✍ Ravi V.J Chari 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 562 KB